We have closed our offices in response to the Covid-19 outbreak and are working remotely. Please send all correspondence by email.

Regulate logo

  • Facebook
  • Twitter

Regulate menu

Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

3 March 2020
Have you found a place to display your poster? We’ve launched a range of resources including a poster and online guide to help people understand what they can expect from pharmacy professionals and...
2 March 2020
Make sure you keep up-to-date with the latest information and advice on the novel coronavirus (COVID-19) and encourage your colleagues to do the same. Joint statement from the health and social care...
2 March 2020
Making sure pharmacy services can be accessed by the people who need to use them Pharmacy owners are well placed to make pharmacy services accessible by having appropriate arrangements in place and...
2 March 2020
The Professional Standards Authority (PSA) has published its review of our performance against the PSA’s Standards of Good Regulation in 2018/19. The PSA found that we met 20 out of 24 of the...
11 December 2019
We have published the findings of our second major survey, which asked pharmacists and pharmacy technicians about their roles and responsibilities, work settings, employment and practice and future...